Skip to main content

Oncocyte Corporation - Common Stock (NQ: OCX )

2.130 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist

Other Filings

Form 10-K/A
Source: SEC/Edgar
April 29, 2018
Form 8-K
Source: SEC/Edgar
April 22, 2018
Form 8-K
Source: SEC/Edgar
April 03, 2018
Form SC 13D/A
Source: SEC/Edgar
April 02, 2018
Form 8-K
Source: SEC/Edgar
April 01, 2018
Form SC 13D/A
Source: SEC/Edgar
March 29, 2018
Form 8-K
Source: SEC/Edgar
March 28, 2018
Form 8-K
Source: SEC/Edgar
March 07, 2018
Form 8-K
Source: SEC/Edgar
January 07, 2018
Form 8-K
Source: SEC/Edgar
November 28, 2017
Form 8-K
Source: SEC/Edgar
November 21, 2017
Form 8-K
Source: SEC/Edgar
November 15, 2017
Form SC 13D/A
Source: SEC/Edgar
November 14, 2017
Form 8-K
Source: SEC/Edgar
November 13, 2017
Form EFFECT
Source: SEC/Edgar
October 15, 2017
Form S-3
Source: SEC/Edgar
October 01, 2017
Form 8-K
Source: SEC/Edgar
August 14, 2017
Form 8-K
Source: SEC/Edgar
July 25, 2017
Form DEFA14A
Source: SEC/Edgar
May 02, 2017
Form 8-K
Source: SEC/Edgar
March 09, 2017
Form 8-K
Source: SEC/Edgar
March 05, 2017
Form 8-K
Source: SEC/Edgar
March 02, 2017
Form 8-K
Source: SEC/Edgar
February 26, 2017
Form 424B3
Source: SEC/Edgar
November 15, 2016
Form 8-K
Source: SEC/Edgar
November 09, 2016
Form EFFECT
Source: SEC/Edgar
October 19, 2016
Form S-1/A
Source: SEC/Edgar
October 18, 2016
Form S-1/A
Source: SEC/Edgar
October 17, 2016
Form S-1
Source: SEC/Edgar
September 25, 2016
Form DEF 14C
Source: SEC/Edgar
September 21, 2016
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.